tiprankstipranks
Advertisement
Advertisement
Goldman suspends rating on Fulcrum Therapeutics
PremiumThe FlyGoldman suspends rating on Fulcrum Therapeutics
1M ago
Midday Fly By: Berkshire investing in Alphabet AI buildout
Premium
The Fly
Midday Fly By: Berkshire investing in Alphabet AI buildout
1M ago
Fulcrum Therapeutics price target lowered to $3 from $8 at BofA
Premium
The Fly
Fulcrum Therapeutics price target lowered to $3 from $8 at BofA
1M ago
Fulcrum Therapeutics downgraded to Market Perform from Outperform at Leerink
PremiumThe FlyFulcrum Therapeutics downgraded to Market Perform from Outperform at Leerink
1M ago
Fulcrum Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Fulcrum Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
1M ago
Fulcrum Therapeutics downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
Fulcrum Therapeutics downgraded to Market Perform from Outperform at Leerink
1M ago
Fulcrum Therapeutics Ends Pociredir, Begins Strategic Review
PremiumCompany AnnouncementsFulcrum Therapeutics Ends Pociredir, Begins Strategic Review
1M ago
Fulcrum discontinues pociredir program in SCD, initiates strategic review
Premium
The Fly
Fulcrum discontinues pociredir program in SCD, initiates strategic review
1M ago
Fulcrum Therapeutics Signals Strong Momentum in Call
Premium
Company Announcements
Fulcrum Therapeutics Signals Strong Momentum in Call
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100